Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study

AIM To build a regional database of chronic patients to define the clinical epidemiology of hepatitis B virus (HBV)-infected patients in the Tuscan public health care system. METHODS This study used a cross-sectional cohort design. We evaluated chronic viral hepatitis patients with HBV referred to the outpatient services of 16 hospital units. Information in the case report forms included main demographic data, blood chemistry data, viral hepatitis markers, instrumental evaluations, and eligibility for treatment or ongoing therapy and liver transplantation. RESULTS Of 4015 chronic viral hepatitis patients, 1096 (27.3%) were HBV infected. The case report form was correctly completed for only 833 patients (64% males, 36% females; mean age 50.1 ± 15.4). Of these HBV-infected patients, 73% were Caucasian, 21% Asian, 4% Central African, 1% North African and 1% American. Stratifying patients by age and nationality, we found that 21.7% of HBV-infected patients were aged < 34 years (only 2.8% were Italian). The most represented routes of transmission were nosocomial/dental procedures (23%), mother-to-child (17%) and sexual transmission (12%). The most represented HBV genotypes were D (72%) and A (14%). Of the patients, 24.7% of patients were HBeAg positive, and 75.3% were HBeAg negative. Of the HBV patients 7% were anti-HDV positive. In the whole cohort, 26.9% were cirrhotic (35.8% aged < 45 years), and 47% were eligible for or currently undergoing treatment, of whom 41.9 % were cirrhotic. CONCLUSION Only 27.3% of chronic viral hepatitis patients were HBV infected. Our results provide evidence of HBV infection in people aged < 34 years, especially in the foreign population not protected by vaccination. In our cohort of patients, liver cirrhosis was also found in young adults.

[1]  N. Salvati,et al.  Long‐term outcome of inactive and active, low viraemic HBeAg‐negative‐hepatitis B virus infection: Benign course towards HBsAg clearance , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[2]  F. Bartalesi,et al.  Non‐invasive assessment of liver fibrosis in patients with HBV‐related chronic liver disease undergoing antiviral treatment: A preliminary study , 2017, European journal of pharmacology.

[3]  S. Milani,et al.  Evolving strategies for liver fibrosis staging: Non-invasive assessment , 2017, World journal of gastroenterology.

[4]  E. Sagnelli,et al.  Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[5]  S. Milani,et al.  Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness. , 2016, World journal of gastroenterology.

[6]  R. Mikolajczyk,et al.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 , 2015, The Lancet.

[7]  Asociacion Latinoamericana para el Estudio del Higado EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. , 2015, Journal of hepatology.

[8]  C. Galli,et al.  Clinical, epidemiological and virological features of acute hepatitis B in Italy , 2015, Infection.

[9]  C. Silvestri,et al.  Hepatitis B and C epidemiology in an urban cohort in Tuscany (Italy). , 2015, Clinics and research in hepatology and gastroenterology.

[10]  Chao Chen,et al.  Individualized management of pregnant women with high hepatitis B virus DNA levels. , 2014, World journal of gastroenterology.

[11]  E. Sagnelli,et al.  Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy. , 2014, World journal of gastroenterology.

[12]  V. Wong,et al.  Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: A prospective cohort study with paired transient elastography examination , 2013, Journal of gastroenterology and hepatology.

[13]  M. Salminen,et al.  Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening , 2013, BMC Infectious Diseases.

[14]  M. Rizzetto,et al.  An Update on Hdv: Virology, Pathogenesis and Treatment , 2013, Antiviral therapy.

[15]  H. Poustchi,et al.  Hepatitis B Virus Infection during Pregnancy: Transmission and Prevention , 2011, Middle East journal of digestive diseases.

[16]  Y. Liaw,et al.  The Natural History of Chronic HBV Infection and Geographical Differences , 2010, Antiviral therapy.

[17]  T. Wilt,et al.  Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence , 2009, Hepatology.

[18]  C. Chu,et al.  Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. , 2004, The American journal of medicine.

[19]  M. Brunetto,et al.  Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. , 2002, Journal of hepatology.